The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((2'-Methyl-[2,4'-bipyridin]-5-yl)methyl)-9H-carbazole-2-carboxamide ID: ALA3970071
PubChem CID: 134154590
Max Phase: Preclinical
Molecular Formula: C25H20N4O
Molecular Weight: 392.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2ccc(CNC(=O)c3ccc4c(c3)[nH]c3ccccc34)cn2)ccn1
Standard InChI: InChI=1S/C25H20N4O/c1-16-12-18(10-11-26-16)22-9-6-17(14-27-22)15-28-25(30)19-7-8-21-20-4-2-3-5-23(20)29-24(21)13-19/h2-14,29H,15H2,1H3,(H,28,30)
Standard InChI Key: MALQHUPHFMVVLA-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
9.0263 -9.4129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1985 -10.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9133 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9133 -11.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1985 -11.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4877 -11.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4877 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8762 -10.0816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0551 -10.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5710 -9.4976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9040 -8.7442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7251 -8.6595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2092 -9.3282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6282 -11.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6282 -12.6895 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3389 -11.4536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0538 -11.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1943 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1943 -11.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4794 -11.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7687 -11.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7687 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4794 -10.2178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3348 -10.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6199 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9050 -10.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9050 -9.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6199 -8.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3348 -9.3940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0497 -10.6298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 2 0
1 13 1 0
14 15 2 0
14 16 1 0
4 14 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
18 26 1 0
24 30 1 0
17 21 1 0
16 17 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.46Molecular Weight (Monoisotopic): 392.1637AlogP: 5.02#Rotatable Bonds: 4Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.82CX Basic pKa: 4.96CX LogP: 3.62CX LogD: 3.62Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: -1.06
References 1. Xu Z, Xu X, O'Laoi R, Ma H, Zheng J, Chen S, Luo L, Hu Z, He S, Li J, Zhang H, Zhang X.. (2016) Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold., 24 (22): [PMID:27692509 ] [10.1016/j.bmc.2016.09.041 ]